# FDA 483 - Intas Pharmaceuticals Ltd. - February 14, 2025

Source: https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-ltd/781f056c-1c11-4569-a13e-48264c8a881f

> FDA 483 for Intas Pharmaceuticals Ltd. on February 14, 2025. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Intas Pharmaceuticals Ltd.
- Inspection Date: 2025-02-14
- Product Type: drugs
- Office Name: Office of Inspections and Investigations

## Related Documents

- [483 - 2017-05-10](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-ltd/60d62c4f-e4ca-403c-bcdf-6c06c5f8d7fd)
- [483 - 2022-08-09](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-ltd/7d6bb7d2-6de0-40cc-aef9-6338a315c741)
- [483 - 2023-12-07](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-ltd/83848914-69b1-4d19-b2fb-ad19cbd9e73f)
- [483 - 2022-08-09](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-ltd/2bf12ea5-ef51-4c78-a178-e074124c4f44)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/intas-pharmaceuticals-ltd/23b75ae0-92f2-496d-87b8-abd03dd683df)

## Related Officers

- [Deepa Singh, PharmD, MS-RAQA](https://www.globalkeysolutions.net/people/deepa-singh-pharmd-ms-raqa/13e0efc4-9823-4c91-a07e-f9fe3a3a6f98)
- [Hamet Touré, PharmD MPH](https://www.globalkeysolutions.net/people/hamet-toure-pharmd-mph/611bd66b-e975-4be5-9ac5-7a2ee17bfd91)
- [investigator](https://www.globalkeysolutions.net/people/amy-hsu/78472f98-f37f-4534-bb3b-43f58a18266e)
- [other](https://www.globalkeysolutions.net/people/hamet-m-toure/9f3726f3-b118-4247-9793-738557aa1ee8)
- [Doan N. Singh](https://www.globalkeysolutions.net/people/doan-n-singh/e52cfbca-5710-4765-8c5e-d534946b648d)

Company: https://www.globalkeysolutions.net/companies/intas-pharmaceuticals-ltd/b19b63c2-446c-413c-9c30-1617f981d92a

Office: https://www.globalkeysolutions.net/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8